@article{db73d16822a046ecbc3cfcbb7feb9ef2,
title = "A prospective evaluation of the fourth national Be Clear on Cancer {\textquoteleft}Blood in Pee{\textquoteright} campaign in England",
abstract = "Objective: To assess the impact of the fourth Be Clear on Cancer (BCoC) {\textquoteleft}Blood in Pee{\textquoteright} (BiP) campaign (July to September 2018) on bladder and kidney cancer symptom awareness and outcomes in England. Methods: In this uncontrolled before and after study, symptom awareness and reported barriers to GP attendance were assessed using panel and one-to-one interviews. The Health Improvement Network (THIN), National Cancer Registration and Analysis Service (NCRAS) and NHS Cancer Waiting Times (CWT) data were analysed to assess the impact on GP attendances, urgent cancer referrals, cancer diagnoses and 1-year survival. Analyses used Poisson, negative binomial and Cox regression. Results: Symptom awareness and intention to consult a GP after one episode of haematuria increased following the campaign. GP attendance with haematuria (rate ratio (RR) 1.17, 95% confidence interval (CI): 1.07–1.28) and urgent cancer referrals (RR 1.18 95% CI: 1.08–1.28) increased following the campaign. Early-stage diagnoses increased for bladder cancer (difference in percentage 2.8%, 95% CI: −0.2%–5.8%), but not for kidney cancer (difference −0.6%, 95% CI: −3.2%–2.1%). Conclusions: The fourth BCoC BiP campaign appears to have been effective in increasing bladder cancer symptom awareness and GP attendances, although long-term impacts are unclear.",
keywords = "awareness, early diagnosis, haematuria, kidney neoplasms, public health, urinary bladder neoplasms",
author = "Merriel, {Samuel William David} and Susan Ball and Bright, {Chloe Jayne} and Vivian Mak and Carolynn Gildea and Lizz Paley and Chris Hyde and William Hamilton and Lucy Elliss‐Brookes",
note = "Funding Information: This work uses data that have been provided by patients and collected by the NHS as part of their care and support. The data are collated, maintained and quality assured by the National Cancer Registration and Analysis Service, which is part of Public Health England (PHE). The authors would also like to acknowledge the following individuals for their input into this research: Jennie Fergusson, Marketing Planning Lead and Peggy Gilbert, Senior Marketing Planning Manager at PHE who facilitated access to marketing results, answered author's questions and provided formative feedback on the early draft. Eleanor Walsh and Karen Eldridge at PHE who delivered the campaign and contributed to the design of the evaluation. Kantar https://uk.kantar.com/ who provided marketing media analysis. Nicola Cooper, Wouter Verstraete, Isobel Tudge, Ravneet Sandhu and Catherine Okello, NCRAS analysts who completed the initial analysis. Jodie Moffat who contributed to the design of the campaign and the original analysis through the BCoC Steering Group and provided formative feedback to early draft. Osa Adeghe (former BCoC Project Officer) and Helen Hill (former BCoC Programme Manager) at PHE who facilitated improved drafts and provided administrative support and quality assurance. Prof Roger Kockelbergh for clinical guidance and support during the design, development and evaluation of the campaign. Past and present members of the Be Clear on Cancer Steering Group for their support and guidance throughout the lifecycle of the campaign and its evaluation. SM is supported by the CanTest Collaborative, which is funded by Cancer Research UK (C8640/Q37A23385). WH is co-director of CanTest. SB is supported by the National Institute for Health Research Applied Research Collaboration South West Peninsula. The views expressed in this publication are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. Funding Information: SM is supported by the CanTest Collaborative, which is funded by Cancer Research UK (C8640/Q37A23385). WH is co‐director of CanTest. SB is supported by the National Institute for Health Research Applied Research Collaboration South West Peninsula. The views expressed in this publication are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. Publisher Copyright: {\textcopyright} 2022 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd.",
year = "2022",
month = sep,
day = "1",
doi = "10.1111/ecc.13606",
language = "English",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "John Wiley & Sons Ltd",
}
